Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer is: yes, most clinical guidelines treat these medicines as long-term rather than short-term tools, though the evidence base beyond two years is still growing. Weight is shaped by biology, not willpower, and for many people the conditions that made it hard to lose weight in the first place do not simply disappear once a target is reached. Whether that means staying on treatment indefinitely, pausing, or stepping down is a clinical question, not a fixed rule, and your prescriber is the right person to work it through with you. These are prescription-only medicines and every decision about continuing or stopping should happen with clinical oversight.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A persistent idea in circulation is that weight loss injections are like antibiotics — you take them, they do their job, and you stop. That framing does not match how the medicines work or what the trials found. GLP-1 and dual GIP/GLP-1 receptor agonists reduce appetite and slow gastric emptying by acting on receptors your body already has. When the medicine is removed, those receptors return to their previous state. The appetite-regulating effect does not linger. That is why the STEP 1 trial of semaglutide (which underpins the NICE appraisal of Wegovy) included a one-year follow-up after participants stopped treatment, and found that on average most of the lost weight returned within that year. Tirzepatide's SURMOUNT programme showed a similar pattern. This is not a flaw in the medicines; it reflects the underlying biology of obesity, which the NHS describes as a long-term condition. If you are still weighing up how an injection to reduce weight loss works in practice, understanding that biology from the outset helps set realistic expectations. Framing these as a short fix sets people up to feel they have failed when the biology reasserts itself. They have not.
The picture differs between Mounjaro and Wegovy, and between NHS and private routes. NICE's recommendation for tirzepatide (TA1026, December 2024) does not include a time-limited cap on treatment duration. What it does include is a clinical review at six months: if someone has not achieved at least 5% body-weight reduction at the highest tolerated dose, continuing treatment should be reassessed. For semaglutide, NICE's TA875 recommendation is specifically scoped to a maximum of two years within an NHS specialist weight management service. That two-year limit is a feature of the NHS commissioning decision, not a finding that semaglutide stops working after 24 months. Private prescribing is not bound by that NHS commissioning cap. At a regulated private pharmacy like nume, your prescriber reviews your case before each repeat order and makes an individualised clinical decision, so there is no blanket end-date built in. If you want to understand more about how the specific timelines compare, our guide on how long you can stay on weight loss injections goes into the detail.
This is the question our prescribers hear most often from people who have been on treatment for several months and are starting to think about the future. The honest answer is that weight regain after stopping is common and happens relatively quickly for most people. It does not happen to everyone, and the degree varies. But the biology is consistent: once the drug's appetite effect is gone, hunger signals return to their pre-treatment pattern. That is not a personal failure; it is pharmacology. The practical implication is that 'going on injections for a bit' and then stopping without a robust lifestyle and dietary foundation in place carries a real risk of ending up back where you started. If you are partway through treatment and wondering about the longer-term plan, the question of whether you have to take weight loss injections for life is worth reading alongside this page, because the answer is genuinely nuanced. Some people do taper and maintain; others find the weight creeps back. The conversation with your prescriber (ideally before you decide to stop rather than after) is the place to make that call. One thing worth knowing is that if you do decide to stop, that decision can be revisited, and our page on whether you can stay on weight loss injections forever explores what ongoing treatment actually looks like for people who choose that route. There is no rule that says stopping once means stopping forever.
Every repeat order at a GPhC-registered pharmacy like ours goes through a fresh clinical review. A named prescriber reads your update (your weight, how you are tolerating the medicine, any changes in your health) before anything is dispensed. There is no subscription that auto-renews without anyone checking. That means long-term use is not simply waved through: it is actively reviewed, which is exactly what responsible long-term prescribing looks like. If you want to explore your options, you might find our overview of weight loss injections a useful starting point, or the weight loss treatments page if you are still deciding between options. For a fuller look at ongoing treatment planning, the question of how long you should stay on weight loss injections covers the decision factors in more depth. Wondering about safe supply when you are planning ahead? Our FAQs cover common logistics questions. Injections themselves require a little routine, sharps disposal is something to set up from day one, and a sharps container makes that straightforward. For a broader perspective on what suits your situation, speaking to our prescribers is the natural next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.